Brachytherapy Study
Juanita Crook, MD, Francois Bachand, MD
This study compares low dose rate permanent seed brachytherapy for prostate cancer to high dose rate (HDR) brachytherapy, looking primarily at Quality of Life and recovery from treatment. The study also involves multiparametric MRI staging of the cancer, and provides the opportunity for Cell Cycle Progression genetic testing of each cancer to look at how aggressive the cancers are and how this correlates with outcome.